Alzamend Neuro, Inc. (ALZN)
1.93
+0.05
(+2.66%)
USD |
NASDAQ |
Mar 04, 11:38
Alzamend Neuro EPS Diluted (Quarterly) : -0.296 for Oct. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Allogene Therapeutics, Inc. | -0.1864 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.001M |
| Total Expenses (Quarterly) | 1.001M |
| Enterprise Value | 2.698M |
| Earnings Yield | -284.8% |
| Normalized Earnings Yield | -284.76 |